Enlivex Therapeutics Stock Quote ENLV - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.1615

Bid

1.16

Ask

1.22

Volume

182,936

1.13 Day's Range 1.24

0.8101 52 Week Range 4.59

Market Cap

24.252M

Previous Close

1.16

Open

1.13

Last Trade

700

1.1615

(formt)

Last Trade Time

Financial Volume

$ 214,563

VWAP

1.1729

Average Volume (3m)

241,300

Shares Outstanding

20,880,000

Dividend Yield

PE Ratio

-0.85

Earnings Per Share (EPS)

-1.39

Revenue

Net Profit

-29.07M

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.enlivex.com

Headquarters

Ness Ziona, Center, Isr

Founded

Enlivex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENLV. The last closing price for Enlivex Therapeutics was $1.16. Over the last year, Enlivex Therapeutics shares have traded in a share price range of $ 0.8101 to $ 4.59.

Enlivex Therapeutics currently has 20,880,000 shares outstanding. The market capitalization of Enlivex Therapeutics is $24.22 million. Enlivex Therapeutics has a price to earnings ratio (PE ratio) of -0.85.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

Ness-Ziona, Israel, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

Nes-Ziona, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis

Nes-Ziona, Israel, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1385	-10.6538461538	1.3	1.3	1.15	168842	1.2245197	CS
4	0.1315	12.7669902913	1.03	1.3465	0.8101	457515	1.2131072	CS
12	-0.3385	-22.5666666667	1.5	1.75	0.8101	241300	1.2883538	CS
26	-0.2885	-19.8965517241	1.45	1.76	0.8101	155616	1.32665089	CS
52	-0.2885	-19.8965517241	1.45	4.59	0.8101	148648	1.85715766	CS
156	-4.8385	-80.6416666667	6	8.64	0.8101	77123	2.78168017	CS
260	-7.5785	-86.7105263158	8.74	29.4	0.8101	172223	8.92296756	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.335 (-36.79%)	1.02B
GOEVCanoo Inc	$ 0.118 (7.08%)	388.43M
NVDANVIDIA Corporation	$ 130.39 (-1.22%)	259.4M
XTIAXTI Aerospace Inc	$ 0.0442 (8.33%)	222.55M